Physician profile
Avi Arora
NPI 1760809198
$1,657.74
in general payments reported to CMS, 2019-2025
15 companies · $69.13 in 2025
The $69.13 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $96.13 · 2021: $73.23 · 2022: $27.08 · 2023: $227 · 2024: $778 · 2025: $69.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625 · Travel and Lodging: $349 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.48 |
| Travel and Lodging | $348.60 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $783.99 | 2019-2025 | Inspire |
| Harmony Biosciences LLC | $173.33 | 2023-2024 | Wakix |
| Alexion Pharmaceuticals, INC. | $125.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.75 | 2019-2024 | Lifevest |
| Eisai INC. | $80.75 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $80.27 | 2019-2021 | |
| Pfizer INC. | $57.06 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $56.67 | 2023-2024 | Xarelto |
| Jazz Pharmaceuticals INC. | $42.10 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.30 | 2021-2022 | |
| Viatris Specialty LLC | $32.03 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $26.72 | 2019-2024 | Zerbaxa, Recarbrio |
| Novartis Pharmaceuticals Corporation | $19.42 | 2019 | |
| Inari Medical, INC. | $18.70 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Chiesi USA, INC. | $15.65 | 2025 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avi Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.